The Interaction of Cisplatin with Signal Transduction Pathways and the Regulation of Apoptosis

  • Alan Eastman

Abstract

There are many ways to kill a cell. In the absence of serum, cells usually die because they have lost a receptor-mediated survival signal. Some cells can be killed by engaging certain receptors such as during glucocorticoid-mediated killing of thymocytes. Cells can also be killed by a multitude of cytotoxic agents including cisplatin. These insults all have a common endpoint: the cells die by apoptosis. There is a network of signals, initially unique to each insult, but eventually converging on a common pathway, only the latter part of which can truly be considered apoptosis. For example, resistance to cisplatin may be mediated by altered drug accumulation, decreased DNA damage or increased DNA repair.1,2 These mechanisms may inhibit apoptosis induced by cisplatin, but they do not rescue a cell from most drugs, and they certainly do not rescue cells from removal of serum. In contrast, the Bcl-2 protein can protect cells from each of these insults, and therefore reflects a step much further along the pathway; a step that is common to multiple insults. Bcl-2 is the prototype of an anti-apoptotic protein, defined as a means to protect cells from multiple unrelated insults. With respect to cancer chemotherapy, Bcl-2 elicits a kind of non-specific multi-drug resistance.

Keywords

Focal Adhesion Kinase Okadaic Acid Intracellular Acidification Acute Myelogenous Leukemia Cell Human Acute Myelogenous Leukemia Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    V.M. Richon, N.A. Schulte, and A. Eastman, Multiple mechanisms of resistance to cis-diamminedichloroplatinum(II) in murine leukemia cells. Cancer Res. 47:2056 (1987).PubMedGoogle Scholar
  2. 2.
    A. Eastman, N. Schulte, N. Sheibani, and CM. Sorenson, Mechanisms of resistance to platinum drugs, in: “Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy,” M. Nicolini, ed., Martinus Nijhoff Publishing, Boston. (1988)Google Scholar
  3. 3.
    J.F.R. Kerr, A.H. Wyllie, and A.R. Currie, Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics, Br. J. Cancer 26:239 (1972).CrossRefPubMedGoogle Scholar
  4. 4.
    A.H. Wyllie, J.F.R. Kerr, and A.R. Currie, Cell death: the significance of apoptosis, Int. Rev. Cytol. 68:251 (1980).CrossRefPubMedGoogle Scholar
  5. 5.
    M.J. Amends, R.G. Morris, and A.H. Wyllie, Apoptosis: the role of the endonuclease, Am. J. Path. 136:593 (1990).Google Scholar
  6. 6.
    C.M. Sorenson and A. Eastman, Mechanism of cis-diamminedichloroplatinum(II)-induced cytotoxicity: role of G2 arrest and DNA double-strand breaks. Cancer Res. 48:4484 (1988).PubMedGoogle Scholar
  7. 7.
    C.M. Sorenson, M.A. Barry, and A. Eastman, Analysis of events associated with cell cycle arrest at G2 and cell death induced by cisplatin, J. Nat. Cancer Inst. 82:749 (1990).CrossRefPubMedGoogle Scholar
  8. 8.
    M.A. Barry, C.A. Behnke, and A. Eastman, Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem. Pharmacol. 40:2353 (1990).CrossRefPubMedGoogle Scholar
  9. 9.
    M.D. Jacobson, J.F. Burne, and M.C Raff, Programmed cell death and Bcl-2 protection in the absence of a nucleus. EMBO J. 13:1899 (1994).PubMedGoogle Scholar
  10. 10.
    CM. Sorenson and A. Eastman, Influence of cis-diamminedichloroplatinum(II) on DNA synthesis and cell cycle progression in excision repair proficient and deficient Chinese hamster ovary cells. Cancer Res. 48:6703 (1988).PubMedGoogle Scholar
  11. U.C. Demarcq, R.T. Bunch, D. Creswell, and A. Eastman, The role of cell cycle progression in cisplatin-induced apoptosis in Chinese hamster ovary cells, Cell Growth Different. 5:983 (1994).Google Scholar
  12. 12.
    I. Zachary and E. Roxengurt, Focal adhesion kinase (p125FAK): a point of convergence in the action of neuropeptides, integrins and oncogenes. Cell 71:891 (1992).CrossRefPubMedGoogle Scholar
  13. 13.
    J.E. Meredith, B. Fazeli, and M.A. Schwartz, The extracellular matrix as a cell survival factor, Molec. Biol. Cell 4:953 (1993).PubMedGoogle Scholar
  14. 14.
    A.M.P. Montgomery, R.A. Reisfeld, and D.A. Cheresh, Integrin αvβ3 rescues cells from apoptosis in three-dimensional dermal collagen, Proc. Natl. Acad. Sci. USA. 91:8856(1994).CrossRefPubMedGoogle Scholar
  15. 15.
    M.A. Schwartz, C Lechene, and D.E. Ingber, Insoluble fibronectin activates the Na/H antiporter by clustering and immobilizing integrin α5β1, independent of cell shape, Proc. Natl. Acad. Sci. USA. 88:7849 (1991).CrossRefPubMedGoogle Scholar
  16. 16.
    K. Swann and M. Whitaker, Stimulation of the Na/H exchanger of sea urchin eggs by phorbol ester. Nature 314:274 (1985).CrossRefPubMedGoogle Scholar
  17. 17.
    C. Sardet, L. Counillon, A. Franchi, and J. Pouyssegur, Growth factors induce phosphorylation of the Na+/H+ antiporter, a glycoprotein of 110 kD. Science 247:723 (1990).CrossRefPubMedGoogle Scholar
  18. 18.
    D.S. Ucker, P.S. Obermiller, W. Eckhart, J.R. Apgar, N.A. Berger, and J. Meyers, Genome digestion is a dispensable consequence of physiological cell death mediated by cytotoxic T lymphocytes, Mol. Cell. Biol. 12:3060 (1992).PubMedGoogle Scholar
  19. 19.
    F. Oberhammer, W. Bursch, W. Parzefall, P. Breit, M. Stadler, and R. Schulte-Hermann, Effects of transforming growth factor β on cell death of cultured rat hepatocytes. Cancer Res. 51:2478 (1991).PubMedGoogle Scholar
  20. 20.
    Z.F. Zakeri, D. Quaglino, T. Latham, and R.A. Lockshin, Delayed internucleosomal DNA fragmentation in programmed cell death. FASEB J. 7:470 (1993).PubMedGoogle Scholar
  21. 21.
    F. Oberhammer, J.W. Wilson, C. Dive, I.D. Morris, J.A. Hickman, A.E. Wakeling, P.R. Walker, and M. Sikorska, Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J. 12:3679 (1993).PubMedGoogle Scholar
  22. 22.
    D.G. Brown, X.-M. Sun, and G.M. Cohen, Dexamethasone-induced apoptosis involves cleavage of DNA to large fragments prior to internucleosomal fragmentation, J. Biol. Chem. 268:3037 (1993).PubMedGoogle Scholar
  23. 23.
    M.A. Barry and A. Eastman, Identification of deoxyribonuclease II as an endonuclease involved in apoptosis, Arch. Biochem. Biophys. 300:440 (1993).CrossRefPubMedGoogle Scholar
  24. 24.
    M.A. Barry and A. Eastman, Endonuclease activation during apoptosis: the role of cytosolic Ca2+ and pH, Biochem. Biophys. Res. Commun. 186:782 (1992).CrossRefPubMedGoogle Scholar
  25. 25.
    M.A. Barry, J.E. Reynolds, and A. Eastman, Etoposide-induced apoptosis in human HL-60 cells is associated with intracellular acidification. Cancer Res. 53:2349 (1993).PubMedGoogle Scholar
  26. 26.
    J. Li and A. Eastman, Apoptosis in an IL-2-dependent cytotoxic T lymphocyte cell line is associated with intracellular acidification: role of the Na+/H+-antiport, J. Biol. Chem. 270:3203 (1995).CrossRefPubMedGoogle Scholar
  27. 27.
    I.H. Madshus, Regulation of intracellular pH in eukaryotic cells. Biochem. J. 250:1 (1988).PubMedGoogle Scholar
  28. 28.
    M. Dohadwala, E.F. da Cruz e Silva, F.L. Hall, R.T. Williams, D.A. Carbonara-Hall, A.C. Nairn, P. Greengard, and N. Berndt, Phosphorylation and inactivation of protein phosphatase 1 by cyclin-dependent kinases, Proc. Natl. Acad. Sci. USA. 91:6408 (1994).CrossRefPubMedGoogle Scholar
  29. 29.
    J. Yuan, S. Shaham, S. Ledoux, H.M. Ellis, and H.R. Horvitz, The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 β-converting enzyme. Cell 75:641 (1993).CrossRefPubMedGoogle Scholar
  30. 30.
    M. Miura, H. Zhu, R. Rotello, E.A. Hartwieg, and J. Yuan, Induction of apoptosis in fibroblasts by IL-1 β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75:653 (1993).CrossRefPubMedGoogle Scholar
  31. 31.
    S.H. Kaufmann, Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res. 49:5870 (1989).PubMedGoogle Scholar
  32. 32.
    Y.A. Lazebnik, S.H. Kaufmann, S. Desnoyers, G.G. Poirier, and W.C. Earnshaw, Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371:346 (1994).CrossRefPubMedGoogle Scholar
  33. 33.
    S.C. Wright, Q.S. Wei, J. Zhong, H. Zheng, D.H. Kinder, and J.W. Larrick, Purification of a 24-kD protease from apoptotic tumor cells that activates DNA fragmentation, J. Exp. Med. 180:2113 (1994).CrossRefPubMedGoogle Scholar
  34. 34.
    A. Eastman, Survival factors, intracellular signal transduction, and the activation of endonucleases in apoptosis, Sem. Cancer Biol. 6:in press (1995).Google Scholar

Copyright information

© Springer Science+Business Media New York 1996

Authors and Affiliations

  • Alan Eastman
    • 1
  1. 1.Department of Pharmacology and ToxicologyDartmouth Medical SchoolHanoverUSA

Personalised recommendations